Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-24 @ 9:30 PM
NCT ID:
NCT00138632
Eligibility Criteria:
Inclusion criteria
* Male ≥ 65 years old or female ≥ 50 years old, with aged related macular degeneration
* Patients with subfoveal choroidal neovascularization secondary to AMD
Exclusion criteria
* Eye disease that may result in visual loss during the study
* Uncontrolled high blood pressure, despite chronic stable treatment: systolic ≥ 140 mmHg, Diastolic ≥ 90 mmHg
* Chronic therapy with topical, local or systemic corticosteroids.
* Use of other investigational drugs within 30 days
* Pregnant or nursing (lactating) women.
Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT00138632
Study Brief:
Protocol Section:
NCT00138632